343 related articles for article (PubMed ID: 27720608)
1. Acetylation of VGLL4 Regulates Hippo-YAP Signaling and Postnatal Cardiac Growth.
Lin Z; Guo H; Cao Y; Zohrabian S; Zhou P; Ma Q; VanDusen N; Guo Y; Zhang J; Stevens SM; Liang F; Quan Q; van Gorp PR; Li A; Dos Remedios C; He A; Bezzerides VJ; Pu WT
Dev Cell; 2016 Nov; 39(4):466-479. PubMed ID: 27720608
[TBL] [Abstract][Full Text] [Related]
2. Hippo Deficiency Leads to Cardiac Dysfunction Accompanied by Cardiomyocyte Dedifferentiation During Pressure Overload.
Ikeda S; Mizushima W; Sciarretta S; Abdellatif M; Zhai P; Mukai R; Fefelova N; Oka SI; Nakamura M; Del Re DP; Farrance I; Park JY; Tian B; Xie LH; Kumar M; Hsu CP; Sadayappan S; Shimokawa H; Lim DS; Sadoshima J
Circ Res; 2019 Jan; 124(2):292-305. PubMed ID: 30582455
[TBL] [Abstract][Full Text] [Related]
3. VGLL4 Protects against Oxidized-LDL-Induced Endothelial Cell Dysfunction and Inflammation by Activating Hippo-YAP/TEAD1 Signaling Pathway.
Xu K; Zhao H; Qiu X; Liu X; Zhao F; Zhao Y
Mediators Inflamm; 2020; 2020():8292173. PubMed ID: 33456372
[TBL] [Abstract][Full Text] [Related]
4. The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity.
Shimomura T; Miyamura N; Hata S; Miura R; Hirayama J; Nishina H
Biochem Biophys Res Commun; 2014 Jan; 443(3):917-23. PubMed ID: 24380865
[TBL] [Abstract][Full Text] [Related]
5. Targeting Hippo pathway by specific interruption of YAP-TEAD interaction using cyclic YAP-like peptides.
Zhou Z; Hu T; Xu Z; Lin Z; Zhang Z; Feng T; Zhu L; Rong Y; Shen H; Luk JM; Zhang X; Qin N
FASEB J; 2015 Feb; 29(2):724-32. PubMed ID: 25384421
[TBL] [Abstract][Full Text] [Related]
6. TEAD1 mediates the oncogenic activities of Hippo-YAP1 signaling in osteosarcoma.
Chai J; Xu S; Guo F
Biochem Biophys Res Commun; 2017 Jun; 488(2):297-302. PubMed ID: 28483529
[TBL] [Abstract][Full Text] [Related]
7. Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling.
Ota M; Sasaki H
Development; 2008 Dec; 135(24):4059-69. PubMed ID: 19004856
[TBL] [Abstract][Full Text] [Related]
8. VGLL4 Selectively Represses YAP-Dependent Gene Induction and Tumorigenic Phenotypes in Breast Cancer.
Zhang Y; Shen H; Withers HG; Yang N; Denson KE; Mussell AL; Truskinovsky A; Fan Q; Gelman IH; Frangou C; Zhang J
Sci Rep; 2017 Jul; 7(1):6190. PubMed ID: 28733631
[TBL] [Abstract][Full Text] [Related]
9. YAP-VGLL4 antagonism defines the major physiological function of the Hippo signaling effector YAP.
Cai J; Choi K; Li H; Pulgar Prieto KD; Zheng Y; Pan D
Genes Dev; 2022 Nov-Dec 1; 36(21-24):1119-1128. PubMed ID: 36522128
[TBL] [Abstract][Full Text] [Related]
10. The Hippo Pathway and YAP/TAZ-TEAD Protein-Protein Interaction as Targets for Regenerative Medicine and Cancer Treatment.
Santucci M; Vignudelli T; Ferrari S; Mor M; Scalvini L; Bolognesi ML; Uliassi E; Costi MP
J Med Chem; 2015 Jun; 58(12):4857-73. PubMed ID: 25719868
[TBL] [Abstract][Full Text] [Related]
11. VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex.
Zhang W; Gao Y; Li P; Shi Z; Guo T; Li F; Han X; Feng Y; Zheng C; Wang Z; Li F; Chen H; Zhou Z; Zhang L; Ji H
Cell Res; 2014 Mar; 24(3):331-43. PubMed ID: 24458094
[TBL] [Abstract][Full Text] [Related]
12. Palmitoylation of TEAD Transcription Factors Is Required for Their Stability and Function in Hippo Pathway Signaling.
Noland CL; Gierke S; Schnier PD; Murray J; Sandoval WN; Sagolla M; Dey A; Hannoush RN; Fairbrother WJ; Cunningham CN
Structure; 2016 Jan; 24(1):179-186. PubMed ID: 26724994
[TBL] [Abstract][Full Text] [Related]
13. SKP2- and OTUD1-regulated non-proteolytic ubiquitination of YAP promotes YAP nuclear localization and activity.
Yao F; Zhou Z; Kim J; Hang Q; Xiao Z; Ton BN; Chang L; Liu N; Zeng L; Wang W; Wang Y; Zhang P; Hu X; Su X; Liang H; Sun Y; Ma L
Nat Commun; 2018 Jun; 9(1):2269. PubMed ID: 29891922
[TBL] [Abstract][Full Text] [Related]
14. Regulation of TP73 transcription by Hippo-YAP signaling.
Wen Z; Wang Y; Qi S; Ma M; Li J; Yu FX
Biochem Biophys Res Commun; 2020 Oct; 531(2):96-104. PubMed ID: 32773110
[TBL] [Abstract][Full Text] [Related]
15. Depletion of VGLL4 Causes Perinatal Lethality without Affecting Myocardial Development.
Sheldon C; Farley A; Ma Q; Pu WT; Lin Z
Cells; 2022 Sep; 11(18):. PubMed ID: 36139407
[TBL] [Abstract][Full Text] [Related]
16. Structural insights into the YAP and TEAD complex.
Li Z; Zhao B; Wang P; Chen F; Dong Z; Yang H; Guan KL; Xu Y
Genes Dev; 2010 Feb; 24(3):235-40. PubMed ID: 20123905
[TBL] [Abstract][Full Text] [Related]
17. Hippo pathway effector Yap promotes cardiac regeneration.
Xin M; Kim Y; Sutherland LB; Murakami M; Qi X; McAnally J; Porrello ER; Mahmoud AI; Tan W; Shelton JM; Richardson JA; Sadek HA; Bassel-Duby R; Olson EN
Proc Natl Acad Sci U S A; 2013 Aug; 110(34):13839-44. PubMed ID: 23918388
[TBL] [Abstract][Full Text] [Related]
18. BMP2-SMAD signaling represses the proliferation of embryonic neural stem cells through YAP.
Yao M; Wang Y; Zhang P; Chen H; Xu Z; Jiao J; Yuan Z
J Neurosci; 2014 Sep; 34(36):12039-48. PubMed ID: 25186749
[TBL] [Abstract][Full Text] [Related]
19. The TEA domain family transcription factor TEAD4 represses murine adipogenesis by recruiting the cofactors VGLL4 and CtBP2 into a transcriptional complex.
Zhang W; Xu J; Li J; Guo T; Jiang D; Feng X; Ma X; He L; Wu W; Yin M; Ge L; Wang Z; Ho MS; Zhao Y; Fei Z; Zhang L
J Biol Chem; 2018 Nov; 293(44):17119-17134. PubMed ID: 30209132
[TBL] [Abstract][Full Text] [Related]
20. VGLL4 and MENIN function as TEAD1 corepressors to block pancreatic β cell proliferation.
Li F; Liu R; Negi V; Yang P; Lee J; Jagannathan R; Moulik M; Yechoor VK
Cell Rep; 2023 Jan; 42(1):111904. PubMed ID: 36662616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
